Advanced Search
MyIDEAS: Login to save this paper or follow this series

International pharmaceutical price differences


Author Info

  • Productivity Commission
Registered author(s):


    The study compares manufacturer prices in Australia and seven other countries for 150 pharmaceuticals listed on the Pharmaceutical Benefits Scheme (PBS), as at 30 June 2000. The comprehensive study found that prices in the USA are between 80 to 160 per cent higher than in Australia, and prices in Canada, the UK and Sweden are around 50 per cent higher. Prices in Australia are closer to those in France, and about the same as those in Spain and New Zealand.

    Download Info

    If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
    File URL:
    Download Restriction: no

    Bibliographic Info

    Paper provided by EconWPA in its series Others with number 0107004.

    as in new window
    Date of creation: 23 Jul 2001
    Date of revision:
    Handle: RePEc:wpa:wuwpot:0107004

    Note: Type of Document - PDF; prepared on IBM PC ; to print on HP;
    Contact details of provider:
    Web page:

    Related research

    Keywords: pharmaceuticals - pricing - drugs - Pharmaceutical Benefit Scheme - PBS - subsidy - price comparisons - therapeutic groups - molecules;

    Find related papers by JEL classification:

    This paper has been announced in the following NEP Reports:


    No references listed on IDEAS
    You can help add them by filling out this form.


    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as in new window

    Cited by:
    1. Quiggin, John, 2005. "How to kill a country? The US-Australia Free Trade Agreement, pharmaceuticals and intellectual property," Risk and Sustainable Management Group Working Papers 151506, University of Queensland, School of Economics.
    2. Gianluca Baio & Laura Magazzini & Antonio Nicita & Fabio Pammolli & Massimo Riccaboni, 2003. "Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica," Working Papers 0-2003, Competitività Regole Mecati (CERM).
    3. Coenen, Michael & Haucap, Justus & Herr, Annika & Kuchinke, Björn A., 2011. "Wettbewerbspotenziale im deutschen Apothekenmarkt," DICE Ordnungspolitische Perspektiven 17, Heinrich‐Heine‐Universität Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).


    This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.


    Access and download statistics


    When requesting a correction, please mention this item's handle: RePEc:wpa:wuwpot:0107004. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (EconWPA).

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If references are entirely missing, you can add them using this form.

    If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.